EUCTR2005-000567-25-IT进行中（未招募）不适用
Tolerance and immunological response in HIV seropositive individuals after NR100063 supplementation
MICO RESEARCH BV0 个研究点开始时间: 2005年9月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
招募中
1 期
Virological and immunological assessment in HIV positive participants on 2DR versus 3DR in a prospective randomized controlled switch trial.EUCTR2020-000685-42-BEGhent University Hospital134
Unknown
不适用
Resistance to HIV InfectionHIV InfectionsNCT00069485National Institute of Allergy and Infectious Diseases (NIAID)100
已完成
不适用
Tolerance and immunological response in human immunodeficiency virus (HIV) seropositive individuals after NR100063 supplementatioHuman immunodeficiency virus (HIV)Infections and InfestationsHuman immunodeficiency virusISRCTN30730587Danone Research B.V. (Netherlands)60
招募中
不适用
Characterization of HIV-1 Antibody Resistance in PatientsB24Unspecified human immunodeficiency virus [HIV] diseaseDRKS00027018niversitätsklinikum Köln210
已完成
不适用
Influenza Vaccine in HIV StudyInfluenza, HumanNCT02632578University of Melbourne57